News and Trends 3 Nov 2022 Positive results of cancer treatment to be presented at Boston conference …in Boston. Alderaan Biotechnology is a preclinical biotech company that focuses on monoclonal antibody development. It will be making announcements about the most recent development of its new antibody candidate,… November 3, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Mar 2024 The 9 hottest private biotech companies in San Diego …four clinical candidates designed to target cancer cells and one clinical candidate aimed at tackling autoimmune diseases. Its lead candidate is an NK cell therapy called FT576 intended for the… March 19, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Mar 2025 12 AI drug discovery companies you should know about …targets backed by experimental validation. Anima currently has 20 preclinical candidates being evaluated for immunology, oncology, and neuroscience indications, with its most advanced candidate indicated for the treatment of lung… March 27, 2025 - 19 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 29 Nov 2016 The ABCs of ADCs: A Review of Antibody Drug Conjugates Antibody therapies have a little sister who is catching up in funding – and hype? In light of now five deaths from Juno’s CAR-T therapy, antibody drug conjugates are attracting… November 29, 2016 - 8 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Nov 2024 8 biotech companies advancing new treatments for breast cancer in 2024 …BioNTech Lead candidate in breast cancer: BNT323 in phase 3 Technology: ADC Recent news: FDA hold lifted for another cancer candidate, BNT326/YL202 Based in Mainz, Germany, BioNtech is a public… November 14, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 May 2025 Nine biotech companies in Montreal to keep an eye on in 2025 …multispecific antibodies for cancer and autoimmune diseases. It has four candidates – Leap 1009 and Leap 1030 for autoimmune diseases, and Leap 1121 and an undisclosed candidate to treat cancer,… May 13, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Oct 2022 Absolute Biotech launches as unified antibody company …well as custom antibody sequencing, antibody engineering and recombinant antibody expression services. Brands within the Absolute Biotech family are: Absolute Antibody, LSBio, Kerafast, Nordic-MUbio, Everest Biotech, and Exalpha. Absolute Biotech… October 4, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 8 Jun 2017 Cambridge Antibody Technology: The History of the UK’s Best Biotech …1989. The company, Cambridge Antibody Technology (CAT), would go on to be the biggest success story in UK biotech after its team discovered the blockbuster therapeutic antibody, Humira, and became… June 8, 2017 - 7 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 10 Feb 2025 Monoclonal antibodies: are they the key to treating Alzheimer’s disease? …of contents Can monoclonal antibody remternetug prevent Alzheimer’s disease? A monoclonal antibody is a protein that binds to specific targets in the body. In the case of Alzheimer’s disease, these… February 10, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Nov 2025 Twice the punch: The emergence of dual-payload antibody and peptide drug conjugates …of the pack, as its drug candidate became the first dual-payload ADC to begin in-human studies when the first patient was dosed in a phase 1 trial in April. The candidate, called… November 18, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jun 2025 Pushing biotech forward in France: 18 companies to know about …broader applicability. Enterome recently presented positive interim results for the phase 2 of its lead candidate, EO2463. The candidate showed a 60% complete response rate in indolent non-Hodgkin’s lymphoma for… June 10, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 May 2025 Nine promising small molecule drug discovery companies to look out for in 2025 …company will use the proceeds to advance its current crop of candidates. 858 Therapeutics Disease areas: Oncology and immunology Lead candidate: ETX-19477 Recent news: Entered into a collaboration with OpenBench… May 16, 2025 - 13 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email